medinfoАктуальные проблемы теоретической и клинической медициныActual Problems of Theoretical and Clinical Medicine2790-12892790-1297Казахстанско-Российский медицинский университет10.24412/2790-1289-2024-2-66-72medinfo-436Research ArticleКЛИНИЧЕСКИЙ СЛУЧАЙCLINICAL CASEБолезнь Паркинсона: краткий обзор и клиническое наблюдениеParkinson's disease: a brief overview and clinical observationhttps://orcid.org/0000-0002-4912-4229КаржаубаеваМ. А.KarzhaubayevaM. A.

Каржаубаева Манчук Амантаевна – старший преподаватель кафедры неврологии

Алматы

Karzhaubaeva Manchuk Amantaevna – senior lecturer at the Department of Neurology

Almaty

manshuk_md90@mail.ruhttps://orcid.org/0009-0000-1933-0550СапарғалиеваА. Б.SapargalievaA. B.

Сапарғалиева Ақмарал Болатбекқызы – резидент-невролог 2 курс

Алматы

Sapargalieva Akmaral Bolatbekkyzy – resident neurologist 2nd year

Almaty

bolatbekovna.1993@mail.ruhttps://orcid.org/0009-0003-1980-5917РысбаеваА. С.RysbaevaA. S.

Рысбаева Айдана Сагидуллаевна – резидент-невролог 2 курс

Алматы

Rysbaeva Aidana Sagidullayevna – resident neurologist 2nd year

Almaty

ailuna17@mail.ruНУО «Казахстанско-Российский медицинский университет»Казахстан«Kazakh-Russian medical university» NEIKazakhstan202429072024026774Copyright © Каржаубаева М.А., Сапарғалиева А.Б., Рысбаева А.С., 20242024Каржаубаева М.А., Сапарғалиева А.Б., Рысбаева А.С.Karzhaubayeva M.A., Sapargalieva A.B., Rysbaeva A.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://kazrosmedjournal.krmu.edu.kz/jour/article/view/436

Болезнь Паркинсона является вторым по распространенности нейродегенеративным заболеванием, и согласно прогнозам, ее распространенность удвоится в течение следующегопоколения. Тем не менее, своевременная диагностика болезни Паркинсона остается сложной задачей, а выявление самых ранних стадий заболевания является серьезной неудовлетвореннойпотребностью.В данной работе мы описали клинический случай диагностики классической формы болезни Паркинсона у больного пожилого возраста, поздней диагностики болезни Паркинсона в отделенииневрологии центральной городской клинической больницы города Алматы.На основании клинических и инструментальных данных выставлен диагноз: Болезнь Паркинсона, акинетико-ригидная форма, без постуральной неустойчивости. Стадия 4 по Хен и Яру.Представленный клинический пример демонстрирует классический вариант болезни Паркинсона. Постепенное развитие симптомов, наличие типичных моторных и немоторных проявлениий у пациента пожилого возраста позволили клинически установить диагноз болезнь Паркинсона.

Parkinson's disease is the second most common neurodegenerative disease, and its prevalence is projected to double over the next generation. Nevertheless, timely diagnosis of Parkinson's disease remainsa difficult task, and the identification of the earliest stages of the disease is a serious unmet need. In this paper, we described a case of diagnosis of the classic form of Parkinson's disease in an elderly patient.In this paper, we describe a clinical case of diagnosing the classic form of Parkinson's disease in an elderly patient with late diagnosis at the Department of Neurology at the Central City Clinical Hospital inAlmaty. Based on clinical and instrumental data, the diagnosis was established as: Parkinson's disease, akinetic-rigid form, without postural instability, Stage 4 according to the Hen and Yaru scale.The presented clinical example demonstrates a classic case of Parkinson's disease. The gradual development of symptoms, along with the presence of typical motor and non-motor manifestations in an elderly patient, allowed for the clinical diagnosis of Parkinson's disease.

Болезнь Паркинсонатремормышечная ригидностьдисфагияParkinson's diseasetremormuscle rigiditydysphagiaReferencesGoldman S. M., Tanner C. Etiology of Parkinson's's disease. In: Jankovic J., Tolosa E., editors. Parkinson's's disease and movement disorders, 3rd ed. – Baltimore, MD: Lippincott-Williams and Wilkins, 1998. – P. 133-158.Goldman, S. M, Tanner, C. (1998). Etiology of Parkinson's's disease. In: Jankovic, J., Tolosa, E., editors. Parkinson's's disease and movement disorders, 3rd ed. – Baltimore, MD: Lippincott-Williams and Wilkins, 133-158.Schrag A., Schott J. M. Epidemiological, clinical, and genetic characteristics of early-onset Parkinsonism. The Lancet. Neurology. – 2006. – Vol. 5. – P. 355-363.Schrag, A., Schott, J. M. (2006). Epidemiological, clinical, and genetic characteristics of early-onset Parkinsonism, The Lancet. Neurology, 5, 355-363.Kalia L. V., Lang A. E. Parkinson’s disease // Lancet. – 2015. – Vol. 386(9996). – Р. 896-912. – DOI: 10.1016/S0140-6736(14)61393-3.Kalia, L. V., Lang, A. E. (2015). Parkinson’s disease. Lancet, 386(9996), 896-912, DOI: 10.1016/S0140-6736(14)61393-3.Poewe W., Seppi K., Tanner C. M. et al. Parkinson disease // Nature Reviews Disease Primers. – 2017. – Vol. 3. – Article No. 17013. – DOI: 10.1038/nrdp.2017.13.Poewe, W., Seppi, K., Tanner, C. M. et al. (2017). Parkinson disease. Nature Reviews Disease Primers, 3, 17013, DOI: 10.1038/nrdp.2017.13.Rajput A. H., Rajput A. Accuracy of Parkinson disease diagnosis unchanged in 2 decades // Neurology. – 2014. – Vol. 83(5). – Р. 386-387. – DOI: 10.1212/WNL.0000000000000653.Rajput, A. H., Rajput, A. (2014). Accuracy of Parkinson disease diagnosis unchanged in 2 decade. Neurology, 83(5), 386-387, DOI: 10.1212/WNL.0000000000000653.Dorsey E. R., Sherer T., Okun M. S., Bloem B. R. The Emerging Evidence of the Parkinson Pandemic // Journal of Parkinson's Disease. – 2018. – Vol. 8(s1). – Р. 3-8. – DOI: 10.3233/JPD-181474.Dorsey, E. R., Sherer, T., Okun, M. S., Bloem, B. R. (2018). The Emerging Evidence of the Parkinson Pandemic Journal of Parkinson's Disease, 8(s1), 3-8, DOI: 10.3233/JPD-181474.Hughes A. J., Daniel S. E., Kilford L., Lees A. J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease. A clinico-pathological study of 100 cases // Journal of Neurology, Neurosurgery and Psychiatry. – 1992. – Vol. 55. – Р. 181-184.Hughes, A. J., Daniel, S. E., Kilford, L., Lees, A. J. (1992). Accuracy of clinical diagnosis of idiopathic Parkinson's disease. A clinico-pathological study of 100 cases. Journal of Neurology, Neurosurgery and Psychiatry, 55, 181-184.Chaudhuri K. R., Schapira A. H. Non-motor symptoms of Parkinson's's disease: Dopaminergic pathophysiology and treatment // Lancet Neurology. – 2009. – Vol. 8. – Р. 464-474.Chaudhuri, K. R., Schapira, A. H. (2009). Nonmotor symptoms of Parkinson's's disease: Dopaminergic pathophysiology and treatment. Lancet Neurology, 8, 464-474.Hely M. A., Reid W. G., Adena M. A., Halliday G. M., Morris J. G. The Sydney multicenter study of Parkinson's's disease: The inevitability of dementia at 20 years // Movement Disorders. – 2008. – Vol. 23. – Р. 837-844.Hely, M. A., Reid, W. G., Adena, M. A., Halliday, G. M., Morris, J. G. (2008). The Sydney multicenter study of Parkinson's's disease: The inevitability of dementia at 20 years. Movement Disorders, 23, 837-844.Rizzo G., Copetti M., Arcuti S., Martino D., Fontana A., Logroscino G. Accuracy of clinical diagnosis of Parkinson's disease: A systematic review and meta- analysis // Neurology. – 2016. – Vol. 86. – Р. 566-576.Rizzo, G., Copetti, M., Arcuti, S., Martino, D., Fontana, A., Logroscino, G. (2016). Accuracy of clinical diagnosis of Parkinson's disease: A systematic review and meta- analysis. Neurology, 86, 566-576.Lehéricy S., Sharman M. A., Santos CLD., Paquin R., Gallea C. Magnetic resonance imaging of the substantia nigra in Parkinson's's disease // Movement Disorders. – 2012. – Vol. 27. – Р. 822-830.Lehéricy, S., Sharman, M. A., Santos, CLD., Paquin, R., Gallea, C. (2012). Magnetic resonance imaging of the substantia nigra in Parkinson's's disease. Movement Disorders, 27, 822-830.Mahlknecht P., Hotter A., Hussl A., Esterhammer R., Schocke M., Seppi K. Significance of MRI in diagnosis and differential diagnosis of Parkinson's disease // Neurodegenerative Diseases. – 2010. – Vol. 7. – Р. 300-318.Mahlknecht, P., Hotter, A., Hussl, A., Esterhammer, R., Schocke, M., Seppi, K. (2010). Significance of MRI in diagnosis and differential diagnosis of Parkinson's disease. Neurodegenerative Diseases, 7, 300-318.Treglia G., Cason E., Stefanelli A., Cocciolillo F., Di Giuda D., Fagioli G. et al. MIBG scintigraphy in differential diagnosis of Parkinsonism: A meta-analysis // Clinical Autonomic Research. – 2012. – Vol. 22. – Р. 43-55.Treglia, G., Cason, E., Stefanelli, A., Cocciolillo, F., Di Giuda, D., Fagioli, G. et al. (2012). MIBG scintigraphy in differential diagnosis of Parkinsonism: A meta-analysis. Clinical Autonomic Research, 22, 43-55.Chen-Plotkin A. S. Unbiased approaches to biomarker discovery in neurodegenerative diseases // Neuron. – 2014. – Vol. 84. – Р. 594-607.Chen-Plotkin, A. S. (2014). Unbiased approaches to biomarker discovery in neurodegenerative diseases. Neuron, 84, 594-607.Swanson C. R., Berlyand Y., Xie S. X., Alcalay R. N., Chahine L. M., Chen-Plotkin A. S. Plasma ApoA1 associates with age at onset and motor severity in early Parkinson's disease patients // Movement Disorders. – 2015. – Vol. 30. – Р. 1648-1656.Swanson, C. R., Berlyand, Y., Xie, S. X., Alcalay, R. N., Chahine, L. M., Chen-Plotkin, A. S. (2015). Plasma ApoA1 associates with age at onset and motor severity in early Parkinson's disease patients. Movement Disorders, 30, 1648-1656.Schapira A. H. V. Recent developments in biomarkers in Parkinson's disease // Current Opinion in Neurology. – 2013. – Vol. 26. – Р. 395-400.Schapira A. H. V. (2013). Recent developments in biomarkers in Parkinson's disease. Current Opinion in Neurology 26, 395-400.LeWitt P. A., Fahn S. Levodopa therapy for Parkinson's disease: A look backward and forward // Neurology. – 2016. – Vol. 86. – Р. 3-12.LeWitt, P. A., Fahn, S. (2016). Levodopa therapy for Parkinson's disease: A look backward and forward. Neurology, 86, 3-12.Katzenschlager R., Hughes A., Evans A., Manson A. J., Hoffman M., Swinn L. et al. Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single-dose challenges // Movement Disorders. – 2005. – Vol. 20. – Р. 151-157.Katzenschlager, R., Hughes, A., Evans, A., Manson, A.J., Hoffman, M., Swinn, L. et al. (2005). Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single-dose challenges. Movement Disorders, 20, 151-157.Pandey S. When to do deep brain stimulation surgery in Parkinson disease? Early or late? // Neurology India. – 2016. – Vol. 64. – Р. 8-9.Pandey, S. (2016). When to do deep brain stimulation surgery in Parkinson disease? Early or late? Neurology India, 64, 8-9.Zhou Z. H., Wu Y. F., Wang X., Hahn Y. Z. The c-Abl inhibitor in Parkinson's disease // Neurology Science. – 2017. – Vol. 38. – Р. 547-552.Zhou, Z. H., Wu, Y. F., Wang, X., Hahn, Y. Z. (2017). The c-Abl inhibitor in Parkinson's disease. Neurology Science, 38, 547-552.

The authors declare that there are no conflicts of interest present.